Orpyx Medical Technologies I Revenue and Competitors

Calgary, CAN

Location

#8114

Growjo Ranking

Estimated Revenue & Valuation

  • Orpyx Medical Technologies I's estimated annual revenue is currently $26.4M per year.(i)
  • Orpyx Medical Technologies I's estimated revenue per employee is $251,000
  • Orpyx Medical Technologies I's total funding is $16.3M.

Employee Data

  • Orpyx Medical Technologies I has 105 Employees.(i)
  • Orpyx Medical Technologies I grew their employee count by 67% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.6M0N/A$1.3BN/A
#2
$59.3M189-3%$19.9MN/A
#3
$2.6M21-32%$26.7MN/A
#4
$267.6M106613%N/AN/A
#5
$28.1M112-23%$45.4MN/A
#6
$20.6M82-4%N/AN/A
#7
$4.9M3922%$6.5MN/A
#8
$6.4M51-37%$91.4MN/A
#9
$16.3M65-7%N/AN/A
#10
$66.5M2120%$64.7MN/A
Add Company

Orpyx® Medical Technologies Inc. empowers people with diabetes to maintain mobility. The company's core product line, the Orpyx SI Sensory Insoles with remote patient monitoring, helps manage and prevent diabetic foot ulcers and limb loss through advanced foot sensor technology and real-time analytics. Orpyx technology is also used by researchers to access clinical-grade plantar pressure data for health and human performance applications in the fields of sports medicine, therapeutic applications, and footwear design.

keywords:N/A

$16.3M

Total Funding

105

Number of Employees

$26.4M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Orpyx Medical Technologies I News

2020-07-16 - Calgary’s Orpyx raises $7.6 million Series A to commercialize, develop shoe-based diabetes tech

Orpyx Medical Technologies, whose smart remote monitoring tech helps prevent diabetic foot ulcers, has closed a $7.6 million Series A round led by Paddock Capital, a Calgary-based investment firm. “Orpyx is on the forefront of technology that enables preventative care.” New and existing invest ...

2020-07-09 - Orpyx Medical Technologies Raises $7.6M in Series A Funding

Orpyx Medical Technologies, a Calgary, Canada-based developer of digital health therapeutics to prevent diabetic foot complications, closed a $7.6M Series A funding round. The round, which brought total funding since inception to $18.5M, was led by Paddock Capital with participation from existi ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37.1M1054%N/A
#2
$25.7M105-5%N/A
#3
$25.7M1052%N/A
#4
$15.9M10661%N/A
#5
$15.9M10610%N/A